VOL. XCIV, NO. 247
★ WIDE MOAT STOCKS & COMPETITIVE ADVANTAGES ★
PRICE: 0 CENTS
GE HealthCare Technologies Inc.
GEHC · The Nasdaq Stock Market LLC
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Request update
Spot something outdated? Send a quick note and source so we can refresh this profile.
Overview
GE HealthCare Technologies Inc. is a global medical technology and pharmaceutical diagnostics company organized in FY2025 into Imaging, Advanced Visualization Solutions (AVS), Patient Care Solutions (PCS), and Pharmaceutical Diagnostics (PDx). Imaging and AVS together were about 70.8% of FY2025 revenue and will combine into Advanced Imaging Solutions beginning with Q2 2026 reporting. The strongest moats are global service coverage, embedded imaging and clinical workflows, and recurring consumables/service revenue tied to mission-critical equipment. PDx adds regulated manufacturing, contrast-media capacity, and supply reliability advantages. Counter-pressures include hospital capital-budget discipline, right-to-repair and interoperability rules, China/local competition, tariff pressure, and procurement-driven price concessions.
Primary segment
Imaging
Market structure
Oligopoly
Market share
—
HHI: —
Coverage
4 segments · 7 tags
Updated 2026-05-29
Segments
Imaging
Diagnostic imaging equipment and related service (CT, MR, molecular imaging, X-ray, women's health) and imaging IT
Revenue
44.8%
Structure
Oligopoly
Pricing
moderate
Share
—
Peers
Advanced Visualization Solutions (AVS)
Ultrasound systems (including handheld) and image-guided / interventional and surgical visualization solutions
Revenue
26%
Structure
Oligopoly
Pricing
moderate
Share
—
Peers
Patient Care Solutions (PCS)
Patient monitoring, anesthesia and respiratory care, maternal-infant care, and diagnostic cardiology devices + consumables and clinical decision software
Revenue
15%
Structure
Oligopoly
Pricing
weak
Share
—
Peers
Pharmaceutical Diagnostics (PDx)
Contrast media and radiopharmaceutical imaging agents (and injectors) used in CT, MR, X-ray, ultrasound, SPECT/PET
Revenue
14.1%
Structure
Oligopoly
Pricing
strong
Share
—
Peers
Moat Claims
Imaging
Diagnostic imaging equipment and related service (CT, MR, molecular imaging, X-ray, women's health) and imaging IT
Revenue_share and operating_profit_share derived from FY2025 segment revenues ($9.245B) and Segment EBIT ($891M) disclosed in the FY2025 Form 10-K; Q1 2026 Imaging revenue was $1.941B. GEHC announced Imaging and AVS will combine into Advanced Imaging Solutions beginning with Q2 2026 reporting.
Service Field Network
Supply
Service Field Network
Strength
Durability
Confidence
Evidence
Large installed base supported by a global field service organization; uptime-critical assets drive service contract attachment and parts revenue.
Erosion risks
- Right-to-repair regulations expanding third-party access
- Independent service organizations (ISOs) undercut OEM service pricing
- Increased remote diagnostics reducing differentiation of onsite service
Leading indicators
- Service contract attach rate
- Parts and service revenue growth vs. equipment shipments
- ISO penetration in key regions
Counterarguments
- Large hospitals may self-service or use ISOs for cost reasons
- Competitors (Siemens/Philips) also have large service networks
Data Workflow Lockin
Demand
Data Workflow Lockin
Strength
Durability
Confidence
Evidence
Imaging software, AI applications, and data integration services embed GEHC into radiology workflows; lifecycle software upgrades reduce willingness to switch OEMs.
Erosion risks
- Open standards and vendor-neutral archives weaken lock-in
- Cloud-native imaging IT vendors displace incumbent stacks
- Interoperability mandates reduce switching frictions
Leading indicators
- Software subscription/ARR growth
- Renewal/retention rates for imaging IT
- Competitive win-loss vs. vendor-neutral archive / cloud PACS vendors
Counterarguments
- Radiology IT often interoperates across vendors (DICOM) so switching is feasible
- Hospitals may decouple software from hardware procurement
Advanced Visualization Solutions (AVS)
Ultrasound systems (including handheld) and image-guided / interventional and surgical visualization solutions
Revenue_share and operating_profit_share derived from FY2025 segment revenues ($5.354B) and Segment EBIT ($1.175B) disclosed in the FY2025 Form 10-K; Q1 2026 AVS revenue was $1.289B. GEHC announced Imaging and AVS will combine into Advanced Imaging Solutions beginning with Q2 2026 reporting.
Training Org Change Costs
Demand
Training Org Change Costs
Strength
Durability
Confidence
Evidence
Specialty- and workflow-aligned ultrasound and interventional systems create clinician training costs (protocols, probe familiarity, workflow habits) and slow competitive displacement.
Erosion risks
- Handheld/POCUS commoditization and price competition
- Rapid feature parity in AI/automation across OEMs
- Low-cost competitors gaining share in emerging markets
Leading indicators
- Premium system mix vs. entry-level mix
- Average selling price (ASP) trends
- Probe attachment and replacement rates
Counterarguments
- Ultrasound switching can be manageable with short training cycles
- Procurement may prioritize price over workflow preferences in budget-constrained hospitals
Ecosystem Complements
Network
Ecosystem Complements
Strength
Durability
Confidence
Evidence
Procedural guidance solutions integrate across modalities (e.g., advanced X-ray + ultrasound) and are complemented by digital/AI software and a broad probe portfolio, supporting stickiness within procedure rooms.
Erosion risks
- Modular best-of-breed systems displace integrated suites
- Open integration standards reduce ecosystem advantage
- Hospital consolidation strengthens bargaining power
Leading indicators
- Growth in procedure-room installed base
- Software attach/subscription growth in AVS
- Service contract attachment rates for interventional systems
Counterarguments
- Large competitors (Siemens/Philips) also offer integrated interventional stacks
- Interoperability requirements can reduce lock-in
Patient Care Solutions (PCS)
Patient monitoring, anesthesia and respiratory care, maternal-infant care, and diagnostic cardiology devices + consumables and clinical decision software
Revenue_share and operating_profit_share derived from FY2025 segment revenues ($3.086B) and Segment EBIT ($209M) disclosed in the FY2025 Form 10-K; Q1 2026 PCS revenue was $711M.
Installed Base Consumables
Demand
Installed Base Consumables
Strength
Durability
Confidence
Evidence
Monitoring fleets drive recurring revenue via proprietary parameters, sensors, and a broad catalog of consumables and service contracts.
Erosion risks
- Third-party compatible disposables/sensors reduce OEM capture
- Hospital procurement standardization squeezes consumables pricing
- Device connectivity standards reduce proprietary parameter advantage
Leading indicators
- Consumables revenue growth vs. installed base growth
- Attach rate of disposable sensors/accessories per monitor
- Gross margin trends in consumables and service
Counterarguments
- Many consumables can be multi-sourced or standardized
- Competitors also bundle monitoring + disposables + service
Data Workflow Lockin
Demand
Data Workflow Lockin
Strength
Durability
Confidence
Evidence
Clinical decision and workflow software aggregates device data across care settings, increasing integration and change-management costs for hospitals.
Erosion risks
- Vendor-neutral monitoring platforms integrated with EHRs displace point solutions
- Cybersecurity incidents reduce trust in connected platforms
- Interoperability requirements reduce switching costs
Leading indicators
- Software recurring revenue growth within PCS
- Renewal rates for monitoring data platforms
- Number of devices/sites connected per customer
Counterarguments
- Vendor-agnostic positioning can reduce lock-in compared with closed platforms
- Hospitals may standardize on EHR-native tooling
Pharmaceutical Diagnostics (PDx)
Contrast media and radiopharmaceutical imaging agents (and injectors) used in CT, MR, X-ray, ultrasound, SPECT/PET
Revenue_share and operating_profit_share derived from FY2025 segment revenues ($2.900B) and Segment EBIT ($872M) disclosed in the FY2025 Form 10-K; Q1 2026 PDx revenue was $835M.
Supply Chain Control
Supply
Supply Chain Control
Strength
Durability
Confidence
Evidence
Reliable, timely global supply of contrast media and radiopharmaceuticals is critical; capacity, logistics, and quality systems create operational barriers and customer preference for dependable suppliers.
Erosion risks
- Manufacturing disruptions (quality issues, plant outages)
- Input constraints (APIs, radioisotopes) and logistics shocks
- Government price controls or tender reforms
Leading indicators
- Backorder rates and reported shortages
- Capacity expansions and ramp milestones (e.g., new fill-finish lines)
- Regulatory inspection outcomes and warning letters
Counterarguments
- Large competitors also invest in global manufacturing networks
- Customers may multi-source to reduce supplier dependency
Compliance Advantage
Legal
Compliance Advantage
Strength
Durability
Confidence
Evidence
Strict regulation and lifecycle monitoring (marketing authorizations, pharmacovigilance, inspections) raise barriers to entry and favor scaled incumbents with mature quality systems.
Erosion risks
- Regulatory changes increasing cost or delaying launches
- Safety concerns driving labeling restrictions or product withdrawal
Leading indicators
- Time-to-approval for new agents
- Regulatory enforcement actions in the category
- Product recall frequency and severity
Counterarguments
- Regulatory compliance is table-stakes for all incumbents; not uniquely proprietary
- Regulators can impose sudden constraints that hurt incumbents too
Installed Base Consumables
Demand
Installed Base Consumables
Strength
Durability
Confidence
Evidence
Contrast media and imaging agents are recurring consumables consumed with procedure volumes; once protocols and injector workflows are set, hospitals tend to prefer continuity of supply and product familiarity.
Erosion risks
- Generic/alternative agents and protocol shifts reduce share
- Procurement consolidation drives price pressure
- Reimbursement changes reduce procedure volumes
Leading indicators
- Contrast media volume growth vs. imaging procedure growth
- Share of wallet in multi-year supply agreements (where disclosed)
- Gross margin trends in PDx
Counterarguments
- Many imaging agents are compatible across OEM imaging platforms
- Hospitals can switch suppliers if supply is stable and pricing is favorable
Scope Economies
Supply
Scope Economies
Strength
Durability
Confidence
Evidence
Combination of imaging equipment, agents, cyclotrons, and advanced visualization software enables integrated offerings and R&D leverage across modalities/disease states.
Erosion risks
- Antitrust scrutiny or bundling restrictions
- Customers prefer best-of-breed sourcing across vendors
Leading indicators
- Cross-selling wins (equipment + agents + software)
- New product launches that span hardware + agent workflows
Counterarguments
- Agents are often used across multiple OEM imaging platforms, limiting bundle lock-in
- Regulators and procurement may resist bundled purchasing
Evidence
a global team of approximately 9,700 sales professionals and 8,900 field service engineers
Shows scale of GEHC service footprint supporting uptime and lifecycle service revenue.
extensive network of field service engineers, global repair centers
Supports existence of an extensive service network and highlights competitive/right-to-repair pressure as an erosion risk.
upgradable through the lifecycle of the equipment
Evidence that lifecycle software and applications remain attached to imaging equipment after purchase.
drive connectivity across healthcare systems
Supports workflow integration across the product lifecycle.
enterprise medical imaging, workflow and cloud solutions
Intelerad acquisition strengthens GEHC imaging workflow and cloud software capabilities.
Showing 5 of 23 sources.
Risks & Indicators
Erosion risks
- Right-to-repair regulations expanding third-party access
- Independent service organizations (ISOs) undercut OEM service pricing
- Increased remote diagnostics reducing differentiation of onsite service
- Open standards and vendor-neutral archives weaken lock-in
- Cloud-native imaging IT vendors displace incumbent stacks
- Interoperability mandates reduce switching frictions
Leading indicators
- Service contract attach rate
- Parts and service revenue growth vs. equipment shipments
- ISO penetration in key regions
- Regulatory momentum on right-to-repair
- Software subscription/ARR growth
- Renewal/retention rates for imaging IT
Research GEHC elsewhere
Curation & Accuracy
This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).
Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.